Authors | |
---|---|
Country | United States |
Language | English |
Subject | Disease causation |
Publisher | Little, Brown and Company |
Publication date | March 2017 |
Pages | 352 |
ISBN | 978-0-316-34369-5 |
OCLC | 974489476 |
614.4 |
Deadliest Enemy: Our War Against Killer Germs is a non-fiction book by epidemiologist Michael T. Osterholm and writer Mark Olshaker, that explores public health emergencies including antimicrobial resistance, emerging infectious disease, and the threat of an influenza pandemic. It proposes a nine-point "battle plan for survival" for dealing with these threats, including solutions to antimicrobial drug resistance.
The book also focuses on the epidemiology of HIV/AIDS, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), toxic shock syndrome, Zika, Ebola, bioterrorism, influenza research, and the antivaccine movement.
The book was first published in March 2017 by Little, Brown and Company.
Michael Osterholm describes his book as "part history, part current affairs, and part blueprint for the future". [1] Top of his concerns are influenza pandemics, antibiotic resistance and bioterrorism, combined with "no clear international governance structure for how we are going to deal with these issues". [1] Focusing on major infectious diseases, he highlights the world's vulnerability to their emerging threats. [2] [3] His concerns include the effects of major outbreaks on medicine and vaccine production, should countries where these are produced be affected. [4]
Content includes a chapter on coronaviruses titled, "SARS and MERS: Harbingers of Things to Come". [5] Other chapters are on the HIV/AIDS, toxic shock syndrome, the 2015–16 Zika virus epidemic, and Ebola outbreaks, covering all the main outbreaks over the previous 30 years, [2] including influenza bioterrorism, [1] Gain-of-function research, influenza research, the antivaccine movement, and antimicrobial resistance. [2] The concept of "game-changing influenza vaccines" is introduced in the chapter "Taking influenza off the table". This provides reasoning and mechanisms for developing vaccines. [2] Solutions to antimicrobial drug resistance are suggested in the chapter titled "Fighting the resistance". [2]
The authors divide infectious diseases into four classes: pathogens that have the potential to cause pandemics; pathogens important to particular regions; endemic diseases; and bioterrorism, dual-use research of concern, and concerns over gain-of-function research, where modifying pathogens in the laboratory might potentially be misused. [2] [6]
The book contains personal experiences, including Osterholm's La Crosse encephalitis, [2] and it uses medical history to assess the threat of pandemics and anti-microbial resistance, while also discussing political responses. [7] The authors propose a nine-point "Battle Plan for Survival" to fight emerging threats, with the aim of informing and inspiring people into public health work. [1]
The book was described by Richard Preston as a "powerful and necessary book" that "offers us not just fear but plans". [2] John M. Barry described the book as Osterholm's way of getting results. [8]
Frank Weimann described the book's "dismal introduction on the threat of epidemics" and the main content as "a disturbing description of what humans are doing to keep" epidemiologists in business. Weimann is convinced by Osterholm's call for planning, research, and funding. [9]
Excerpts from the book appeared in Wired and on MPR News. [10] [11] It was listed in the Johns Hopkins Bloomberg School of Public Health's best books of 2017. [12]
Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from the effects of antimicrobials. All classes of microbes can evolve resistance where the drugs are no longer effective. Fungi evolve antifungal resistance, viruses evolve antiviral resistance, protozoa evolve antiprotozoal resistance, and bacteria evolve antibiotic resistance. Together all of these come under the umbrella of antimicrobial resistance. Microbes resistant to multiple antimicrobials are called multidrug resistant (MDR) and are sometimes referred to as superbugs. Although antimicrobial resistance is a naturally occurring process, it is often the result of improper usage of the drugs and management of the infections.
Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents include bacteria, viruses, insects, fungi, and/or toxins, and may be in a naturally occurring or a human-modified form, in much the same way as in biological warfare. Further, modern agribusiness is vulnerable to anti-agricultural attacks by terrorists, and such attacks can seriously damage economy as well as consumer confidence. The latter destructive activity is called agrobioterrorism and is a subtype of agro-terrorism.
A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.
A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human to a human and vice versa.
An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.
The National Microbiology Laboratory (NML) is part of the Public Health Agency of Canada (PHAC), the agency of the Government of Canada that is responsible for public health, health emergency preparedness and response, and infectious and chronic disease control and prevention.
Stewart Simonson is the Assistant Director-General of the World Health Organization responsible for the WHO Office at the United Nations and the WHO-US Liaison Office. He also serves as the Director-General's Special Representative for UN Reform. Prior to his assignment in New York, Simonson was the Assistant Director-General for the General Management Group at WHO headquarters in Geneva, Switzerland.
Michael Thomas Osterholm is an American epidemiologist, Regents Professor at the University of Minnesota School of Public Health, and director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.
The ICEID or International Conference on Emerging Infectious Diseases is a conference for public health professionals on the subject of emerging infectious diseases.
The Biomedical Advanced Research and Development Authority (BARDA)' is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.
The Center for Infectious Disease Research and Policy (CIDRAP) is a center within the University of Minnesota that focuses on addressing public health preparedness and emerging infectious disease response. It was founded in 2001 by Dr. Michael Osterholm, in order to "prevent illness and death from infectious diseases through epidemiological research and rapid translation of scientific information into real-world practical applications and solutions". It is not part of the Center for Disease Control or National Institute of Health.
Sir Jeremy James Farrar is a British medical researcher who serves as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Ira M. Longini is an American biostatistician and infectious disease epidemiologist.
Mark Olshaker is an American author from Washington, D.C. who frequently collaborates with FBI agent John E. Douglas in writing books about criminal and investigative psychology. In 1995, they formed Mindhunters, Inc. and later released Mindhunter: Inside the FBI's Elite Serial Crime Unit, which was made into a Netflix series Mindhunter in 2017.
Disease X is a placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on their shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic. The WHO adopted the placeholder name to ensure that their planning was sufficiently flexible to adapt to an unknown pathogen. Director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci stated that the concept of Disease X would encourage WHO projects to focus their research efforts on entire classes of viruses, instead of just individual strains, thus improving WHO capability to respond to unforeseen strains. In 2020, experts, including some of the WHO's own expert advisors, speculated that COVID-19, caused by the SARS-CoV-2 virus strain, met the requirements to be the first Disease X.
Health security is a concept that encompasses activities and measures across sovereign boundaries that mitigates public health incidents to ensure the health of populations. It is an evolving paradigm within the fields of international relations and security studies. Proponents of health security posit that all states have a responsibility to protect the health and wellbeing of their populations. Opponents suggest health security impacts civil liberties and the equal distribution of resources.
Laura H. Kahn is a native Californian. She is an author, lecturer, a general internist physician, and a research scholar with the Program on Science and Global Security at the Woodrow Wilson School of Public and International Affairs at Princeton University in New Jersey. She is the co-founder, of One Health Initiative. She is an online columnist for the Bulletin of the Atomic Scientists. She is an expert advisor and author in the field of zoonosis. Zoonosis is the study of infectious diseases where cross-species illnesses that are caused by bacteria, viruses, or parasites spread from non-human animals to humans. She is the author of Who's in Charge? Leadership During Epidemics, Bioterror Attacks, and Other Public Health Crises
Pandemic prevention is the organization and management of preventive measures against pandemics. Those include measures to reduce causes of new infectious diseases and measures to prevent outbreaks and epidemics from becoming pandemics.
Arnold Monto is an American physician and epidemiologist. At the University of Michigan School of Public Health, Monto is the Thomas Francis, Jr. Collegiate Professor Emeritus of Public Health, professor emeritus of both epidemiology and global public health, and co-director of the Michigan Center for Respiratory Virus Research & Response. His research focuses on the occurrence, prevention, and treatment of viral respiratory infections in industrialized and developing countries' populations.